United States of America
Related tags
New gastric cancer indication - FDA approved
Since 1988, laboratories around the world have relied on the diagnostic accuracy of Dako HER2 testing for breast cancer. Now new hope is given for patients with gastric cancer. A recent clinical study shows that HercepTest™ and HER2 FISH pharmDx™ Kit accurately identify patients with gastric cancer who may benefit from trastuzumab treatment.*
*Lancet 2010; 376:687-07
Dako provides a variety of material for HER2 testing in Gastric Cancer.
Would you like further information?
Please contact your local Dako representative for additional material:
Would you like further information?
Please contact your local Dako representative for additional material:
HercepTest™ material:
HercepTest™ - Interpretation Manual - Gastric Cancer
(Literature Order No.: 29028)
HER2 - Gastric Cancer Brochure
(Literature Order No. 29029)
Guidelines for Scoring HercepTest™ - Gastric Cancer
(Literature Order No.: 38662)
HER2 IQFISH material:
HER2 IQFISH pharmDx™ Interpretation Guide - Gastric Cancer
(Literature Order No.: 29050)